FcRn

Assets acting on this target.

Class
FcRn blocker (IgG1 Fc fragment)

By indication

FcRn drugs compared

3 drugs, stage by indication
3 drugs acting on FcRn: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Efgartigimod AlfaVyvgartargenx, Zai Labantibody fragmentApprovedApproved in Generalized Myasthenia Gravis; Approved in Myasthenia Gravis
Efgartigimod alfa and hyaluronidase (Vyvgart Hytrulo)Vyvgart Hytruloargenxantibody fragmentApprovedApproved in Chronic Inflammatory Demyelinating Polyneuropathy; Approved in Generalized Myasthenia Gravis
ImeroprubartHanAll BioPharma, Immunovant, Inc., Roivant Sciences Ltd.monoclonal antibodyPhase 3Phase 3 in Myasthenia Gravis; Phase 2 in Chronic Inflammatory Demyelinating Polyneuropathy; Phase 2 in Graves' Disease; Phase 2 in Rheumatoid Arthritis; Phase 2 in Sjögren's Disease

← all mechanisms